RT Journal Article
SR Electronic
T1 Experimental Methods of Investigating Airborne Indoor Virus-Transmissions Adapted to Several Ventilation Measures
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.01.10.22268982
DO 10.1101/2022.01.10.22268982
A1 Lukas Siebler
A1 Maurizio Calandri
A1 Torben Rathje
A1 Konstantinos Stergiaropoulos
YR 2022
UL http://medrxiv.org/content/early/2022/01/10/2022.01.10.22268982.abstract
AB This study introduces a principle, which unifies two experimental methods for airborne indoor virus-transmissions adapted to several ventilation measures. A first-time comparison of mechanical/natural ventilation and air purifiers with regard to infection risks is achieved. Effortful computational fluid dynamics demand detailed boundary conditions for accurate calculations of indoor airflows, which are often unknown. Hence a suitable, simple and generalized experimental set up for identifying the spatial and temporal infection risk for different ventilation measures is required. A trace gas method is suitable for mechanical and natural ventilation with outdoor air exchange. For an accurate assessment of air purifiers based on filtration a surrogate particle method is appropriate. The release of a controlled rate of either trace gas or particles simulates an infectious person releasing virus material. Surrounding substance concentration measurements identify the neighborhood exposure. One key aspect of the study is to prove that the requirement of concordant results of both methods is fulfilled. This is the only way to ensure that the comparison of different ventilation measures described above is reliable. Two examples (a two person office, several classrooms) show how practical both methods are and how the principle is applicable for different types and sizes of rooms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors